C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue PEBK Q4 2025 Earnings EPS of 121 Reported Stock Dips Slightly TDS Q1 2026 Earnings Massive EPS Surprise of 3475 Amid Stock Decline RLX Technology Q1 2026 Earnings EPS Beats Estimates by 24 Amid Revenue Disclosure Gap VKTX Q1 2026 Earnings WiderthanExpected Loss in a PreRevenue Stage BNR Q3 2022 Earnings Narrower Loss Surpasses Estimates Stock Declines